Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nasdaq  >  Medivation Inc    MDVN   US58501N1019

MEDIVATION INC (MDVN)

53
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Medivation Inc : Medivation Announces Participation at Upcoming Investor Conferences

10/30/2013 | 04:34pm US/Eastern

SAN FRANCISCO, CA -- (Marketwired) -- 10/28/13 -- Medivation, Inc. (NASDAQ: MDVN) today announced that it will host a live teleconference with management to discuss third quarter 2013 financial results and provide a general business update on November 12, 2013 at 4:30 p.m. Eastern Time. A press release for the third quarter of 2013 will be released after markets close on November 12, 2013.

Interested parties may listen to the live teleconference by calling 877-303-2523 from the U.S. or +1-253-237-1755 internationally. Individuals may access the live audio webcast by visiting: http://investors.medivation.com/events.cfm.

About Medivation
Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel therapies to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their families. For more information, please visit us at www.medivation.com.

Contacts:
Patrick Machado
Chief Business & Financial Officer
(415) 829-4101

Anne Bowdidge
Sr. Director, Investor Relations
(650) 218-6900

Source: Medivation

News Provided by Acquire Media

distributed by
React to this article
Latest news on MEDIVATION INC
06/29 MEDIVATION : Voted Three Years in a Row Among Top Workplaces in the San Francisc..
06/19 MEDIVATION : Change in Directors or Principal Officers, Submission of Matters to..
06/19 MEDIVATION : Regulation FD Disclosure, Financial Statements and Exhibits (form 8..
06/19 MEDIVATION : to Redeem Outstanding Convertible Notes Due 2017
06/17 MEDIVATION : and Astellas Announce Enrollment of the First Patients in Advanced ..
06/01 MEDIVATION : New Enzalutamide Data in Triple-Negative Breast Cancer Presented at..
05/28 MEDIVATION : Change in Directors or Principal Officers (form 8-K)
05/28 MEDIVATION : Names Andrew Powell General Counsel
05/28 MEDIVATION : Names Andrew Powell General Counsel
05/27 ASTELLAS PHARMA : And Medivation Announce New Enzalutamide Data Presented At The..
Advertisement
Chart
Duration : Period :
Medivation Inc Technical Analysis Chart | MDVN | US58501N1019 | 4-Traders
Income Statement Evolution
More Financials